medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2019, Number 4

Next >>

Rev Mex Urol 2019; 79 (4)

Evaluation of the efficacy and safety of sacral neuromodulation as voiding dysfunction treatment and its effects on quality of life in patients seen at a Mexican referral center.

Cervantes-Palma C, Campos-Salcedo JG, Mendoza-Álvarez LA, López-Silvestre JC, Díaz-Gómez C, Reyes-Equihua JL, Estrada-Carrasco CE, Torres-Gómez JJ, Hernández-Palacios GA, Bravo-Castro EI, Islas-García JJO, Martínez-Alonso IA, Izquierdo-Luna JS, Germán-Garrido CO, Ruíz-Hernández JA, Avilés-Díaz DJP, Hernández-Valadez OF, Acevedo-Monroy JDG, Victorio-Vargas OD, Cruz-Ordóñez SX, Blas-Martínez JM, Chein-Vázquez MF, Tarot-Chocooj CP, Hernández-Molina S, Cruz-Valentín LG

Language: Spanish
References: 19
Page: 1-9
PDF size: 155.48 Kb.


ABSTRACT

Background: Sacral neuromodulation is a therapy for modulating and restoring the spinal reflexes that influence micturition and defecation. Multiple indications for its implementation are currently approved. There are few studies in Mexico that evaluate the treatment’s efficacy and safety.
Objetive: To evaluate the efficacy and safety of sacral neuromodulation in the treatment of chronic voiding dysfunction, and its effect on quality of life, in patients seen at the Hospital Central Militar.
Materials and methods: A case record review of the patients treated with sacral neuromodulation due to chronic voiding dysfunction, within the time frame of January 1, 2010 to June 30, 2018, was conducted. Quality of life was evaluated through the SF-36 v2 (Mexican version) and ICIQSF instruments and treatment efficacy was assessed through voiding diaries and urodynamic parameters. The ibm spss 22.0 program was utilized.
Results: Forty-one patients (16 males and 25 females) with chronic voiding dysfunction were included. All the patients presented with symptom improvement in the trial phase of the therapy and underwent definitive neurostimulator placement. Improvement above 65% in quality of life, bladder capacity, and postmicturition volume was achieved.
Conclusions: Our results were similar to those reported in the literature, in relation to efficacy, safety, and improved quality of life. Sacral neuromodulation is a durable therapy for nonobstructive voiding dysfunction, which can also be reversed. Prospective studies are needed to evaluate its medium-term and long-term efficacy.


REFERENCES

  1. Kessler TM, La Framboise D, Trelle S, Fowler CJ, Kiss G, Pannek J, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and metaanalysis. Eur Urol. 2010;58(6):865–74. doi: https://doi.org/10.1016/j.eururo.2010.09.024

  2. Schreiner L, Santos TG dos, Souza ABA de, Nygaard CC, Filho IG da S, Schreiner L, et al. Electrical Stimulation for Urinary Incontinence in Women: A Systematic Review. International braz j urol. 2013;39(4):454–64. Available from: http://www.scielo.br/scielo.php?script=sci_ abstract&pid=S1677-55382013000400454&lng =en&nrm=iso&tlng=en

  3. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ. 2002;324(7351):1417. doi: https://doi.org/10.1136/bmj.324.7351.1417

  4. Arlandis-Guzmán S, Blasco-Hernández P, Castro-Díaz D, Garmendía-Larrea JC, Jiménez-Cidre MÁ, Resel-Folkersma L. Guía de estandarización para neuromodulación sacra en urología. La Coruña: Sociedad Iberoamericana de Neurourología y Uroginecología-Asociación Española de Urología; 2015. 45 p.

  5. Shaker HS, Hassouna M. Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention. J Urol. 1998;159(5):1476–8. doi: https://doi. org/10.1097/00005392-199805000-00017

  6. Velarde-Jurado E, Avila-Figueroa C. Evaluación de la calidad de vida. Salud Pública de México. 2002;44(4):349–61. Available from: http:// www.scielo.org.mx/scielo.php?script=sci_ abstract&pid=S0036-36342002000400009&lng =es&nrm=iso&tlng=es

  7. Dahms SE, Hohenfellner M, Thüroff JW. Sacral neurostimulation and neuromodulation in urological practice. Curr Opin Urol. 2000;10(4):329–35.

  8. Brazzelli M, Murray A, Fraser C. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol. 2006;175(3 Pt 1):835–41. doi: https://doi. org/10.1016/S0022-5347(05)00326-5

  9. Shaker HS, Hassouna M. Sacral nerve root neuromodulation: an effective treatment for refractory urge incontinence. J Urol. 1998;159(5):1516–9. doi: https://doi. org/10.1097/00005392-199805000-00028

  10. Cappellano F, Bertapelle P, Spinelli M, Catanzaro F, Carone R, Zanollo A, et al. Quality of life assessment in patients who undergo sacral neuromodulation implantation for urge incontinence: an additional tool for evaluating outcome. J Urol. 2001;166(6):2277–80.

  11. Chartier-Kastler E, Ballanger P, Belas M, Biserte J, Corbel L, Gamé X, et al. [Sacral neuromodulation with InterStimTM system: Results from the French national register]. Prog Urol. 2011;21(3):209–17. doi: https://doi. org/10.1016/j.purol.2010.05.008

  12. Wallace PA, Lane FL, Noblett KL. Sacral nerve neuromodulation in patients with underlying neurologic disease. Am J Obstet Gynecol. 2007;197(1):96.e1-5. doi: https://doi. org/10.1016/j.ajog.2007.04.016

  13. Chaabane W, Guillotreau J, Castel-Lacanal E, Abu-Anz S, De Boissezon X, Malavaud B, et al. Sacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic study. Neurourol Urodyn. 2011;30(4):547–50. doi: https://doi.org/10.1002/nau.21009

  14. Van Rey FS, Heesakkers JPFA. Applications of neurostimulation for urinary storage and voiding dysfunction in neurological patients. Urol Int. 2008;81(4):373–8. doi: https://doi. org/10.1159/000167831

  15. Hohenfellner M, Humke J, Hampel C, Dahms S, Matzel K, Roth S, et al. Chronic sacral neuromodulation for treatment of neurogenic bladder dysfunction: long-term results with unilateral implants. Urology. 2001;58(6):887– 92. doi: https://doi.org/10.1016/s0090- 4295(01)01412-1

  16. Spinelli M, Bertapelle P, Cappellano F, Zanollo A, Carone R, Catanzaro F, et al. Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. J Urol. 2001;166(2):541–5.

  17. Jonas U, Fowler CJ, Chancellor MB, Elhilali MM, Fall M, Gajewski JB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol. 2001;165(1):15–9. doi: https://doi. org/10.1097/00005392-200101000-00004

  18. Lavano A, Volpentesta G, Aloisi M, Veltri C, Piragine G, Signorelli CD. Use of chronic sacral nerve stimulation in neurological voiding disorders. J Neurosurg Sci. 2004;48(4):157–9.

  19. Sutherland SE, Lavers A, Carlson A, Holtz C, Kesha J, Siegel SW. Sacral nerve stimulation for voiding dysfunction: One institution’s 11-year experience. Neurourol Urodyn. 2007;26(1):19– 28; discussion 36. doi: https://doi.org/10.1002/ nau.20345




2020     |     www.medigraphic.com